Telomere and Telomerase as Targets for Cancer Therapy

被引：44
作者：
Tian, Xiaoping [1 ]
Chen, Bo [1 ]
Liu, Xiaochuan [1 ]
机构：
[1] Zhejiang Sci Tech Univ, Bioengn Inst, Life Sci Coll, Hangzhou 310018, Peoples R China
来源：
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | 2010年 / 160卷 / 05期
关键词：
Telomere; Telomerase; Telomere dysfunction; Telomerase RNA; Cancer therapy; HTERT MESSENGER-RNA; REVERSE-TRANSCRIPTASE EXPRESSION; TUMOR-ASSOCIATED ANTIGEN; CYTOTOXIC T-LYMPHOCYTES; SINGLE-STRAND OVERHANG; GROWTH IN-VITRO; SUICIDE GENE; STEM-CELLS; CELLULAR SENESCENCE; INHIBITION;
D O I：
10.1007/s12010-009-8633-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Telomere maintenance and telomerase reactivation is essential for the transformation of most human cancer cells. Telomere shortening to the threshold length, mutations of the telomere-associated proteins, and/or telomerase RNA lead to telomeric dysfunction and therefore genomic instability. Telomerase up-regulation in 85% of human cancer cells has become a hallmark of cancers, hence a promising target for anticancer therapy. In this review, we discuss the mechanism of cancer due to telomere dysfunction and the resulting biological effects, the control of telomerase activity, and the new developments in cancer therapies targeting telomere and telomerase.
引用
收藏
页码：1460 / 1472
页数：13
相关论文
共 97 条
  • [1] When ATPases pontin and reptin met telomerase
    Baek, Sung Hee
    [J]. DEVELOPMENTAL CELL, 2008, 14 (04) : 459 - 461
  • [2] Telomeres and DNA double-strand breaks: ever the twain shall meet?
    Bailey, S. M.
    Cornforth, M. N.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (22) : 2956 - 2964
  • [3] DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes
    Bailey, SM
    Meyne, J
    Chen, DJ
    Kurimasa, A
    Li, GC
    Lehnert, BE
    Goodwin, EH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 14899 - 14904
  • [4] Telomere position effect in human cells
    Baur, JA
    Zou, Y
    Shay, JW
    Wright, WE
    [J]. SCIENCE, 2001, 292 (5524) : 2075 - 2077
  • [5] Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
    Bernhardt, S. L.
    Gjertsen, M. K.
    Trachsel, S.
    Moller, M.
    Eriksen, J. A.
    Meo, M.
    Buanes, T.
    Gaudernack, G.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (11) : 1474 - 1482
  • [6] Telomeric localization of TRF2, a novel human telobox protein
    Bilaud, T
    Brun, C
    Ancelin, K
    Koering, CE
    Laroche, T
    Gilson, E
    [J]. NATURE GENETICS, 1997, 17 (02) : 236 - 239
  • [7] Telomeres and telomerase: their mechanisms of action and the effects of altering their functions
    Blackburn, EH
    [J]. FEBS LETTERS, 2005, 579 (04): : 859 - 862
  • [8] Boldrini L, 2006, INT J ONCOL, V28, P1555
  • [9] The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function
    Burger, AM
    Dai, FP
    Schultes, CM
    Reszka, AP
    Moore, MJ
    Double, JA
    Neidle, S
    [J]. CANCER RESEARCH, 2005, 65 (04) : 1489 - 1496
  • [10] Telomerase-based immunotherapy of cancer
    Carpenter, Erica L.
    Vonderheide, Robert H.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (10) : 1031 - 1039
12345678910